Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement.

[1]  K. Huffman,et al.  Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial , 2023, Nature Aging.

[2]  V. Fuster,et al.  TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease , 2023, Nature Cardiovascular Research.

[3]  M. Serrano,et al.  Hallmarks of aging: An expanding universe , 2022, Cell.

[4]  D. Seals,et al.  Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin , 2022, Aging cell.

[5]  Philip D. Blood,et al.  NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health. , 2022, Nature aging.

[6]  P. Natarajan.  Genomic Aging, Clonal Hematopoiesis, and Cardiovascular Disease , 2022, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M. Packer.  Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis , 2022, Circulation.

[8]  A. Galecki,et al.  Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice , 2022, Aging cell.

[9]  J. Kirkland,et al.  Cellular senescence and senolytics: the path to the clinic , 2022, Nature Medicine.

[10]  T. Fall,et al.  Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality , 2022, Science.

[11]  David M. Wilson,et al.  Connecting aging biology and inflammation in the omics era , 2022, The Journal of clinical investigation.

[12]  Wei Peng,et al.  Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases , 2022, Aging and disease.

[13]  G. Pasterkamp,et al.  Protective role of chaperone-mediated autophagy against atherosclerosis , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Kuchel,et al.  Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization , 2022, Aging cell.

[15]  L. Niedernhofer,et al.  Targeting cellular senescence with senotherapeutics: senolytics and senomorphics , 2022, The FEBS journal.

[16]  J. Tardif,et al.  Colchicine in Cardiovascular Disease: In-Depth Review , 2022, Circulation.

[17]  N. LeBrasseur,et al.  A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues , 2021, Nature Communications.

[18]  M. Evans,et al.  The accelerated aging phenotype: The role of race and social determinants of health on aging , 2021, Ageing Research Reviews.

[19]  J. Campisi,et al.  The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice , 2021, Nature Metabolism.

[20]  Andrew J. Scott.  The longevity economy. , 2021, The Lancet. Healthy longevity.

[21]  D. Belsky,et al.  DunedinPACE, a DNA methylation biomarker of the pace of aging , 2021, eLife.

[22]  S. Selvaraj,et al.  Acute Echocardiographic Effects of Exogenous Ketone Administration in Healthy Participants. , 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  G. Medea,et al.  All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[24]  J. Kirkland,et al.  Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation , 2021, Plastic and reconstructive surgery.

[25]  J. Kirkland,et al.  Impact of Senescent Cell Subtypes on Tissue Dysfunction and Repair: Importance and Research Questions , 2021, Mechanisms of Ageing and Development.

[26]  Mark M. Davis,et al.  An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging , 2021, Nature Aging.

[27]  H. Heerspink,et al.  SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications , 2021, The Lancet.

[28]  A. Caspi,et al.  Moving geroscience from the bench to clinical care and health policy , 2021, Journal of the American Geriatrics Society.

[29]  M. Bennett,et al.  Efficacy and limitations of senolysis in atherosclerosis , 2021, Cardiovascular research.

[30]  J. Saavedra.  Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. , 2021, Physiology.

[31]  R. DeFronzo,et al.  FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19 , 2021, Journal of the American College of Cardiology.

[32]  R. de Cabo,et al.  Intermittent Fasting: From Calories to Time Restriction , 2021, GeroScience.

[33]  Xue-Lian Zhang,et al.  The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24) , 2021, Scientific Reports.

[34]  R. D. de Boer,et al.  Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC Focus Seminar. , 2021, Journal of the American College of Cardiology.

[35]  E. Hoogendijk,et al.  Course of frailty stratified by physical and mental multimorbidity patterns: a 5-year follow-up of 92,640 participants of the LifeLines cohort study , 2021, BMC Medicine.

[36]  Seungpyo Hong,et al.  Association between Gut Microbiome and Frailty in the Older Adult Population in Korea. , 2021, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  R. Varadhan,et al.  The physical frailty syndrome as a transition from homeostatic symphony to cacophony , 2021, Nature Aging.

[38]  Jianshe Wei,et al.  The Molecular Mechanisms Associated with Aerobic Exercise-Induced Cardiac Regeneration , 2020, Biomolecules.

[39]  B. McCormick,et al.  Aging, Frailty, and the Microbiome: How Dysbiosis Influences Human Aging and Disease. , 2020, Gastroenterology.

[40]  L. Ferrucci,et al.  Cardiovascular health and mitochondrial function: testing an association. , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  D. Forman,et al.  PHYSICAL FRAILTY PHENOTYPE AND THE DEVELOPMENT OF GERIATRIC SYNDROMES IN OLDER ADULTS WITH CORONARY HEART DISEASE. , 2020, The American journal of medicine.

[42]  A. Moore,et al.  Plasma proteomic biomarker signature of age predicts health and life span , 2020, eLife.

[43]  M. Bogue,et al.  Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects , 2020, Aging cell.

[44]  M. Xia,et al.  Intermittent Fasting Improves Cardiometabolic Risk Factors and Alters Gut Microbiota in Metabolic Syndrome Patients. , 2020, The Journal of clinical endocrinology and metabolism.

[45]  D. Allison,et al.  Canagliflozin extends life span in genetically heterogeneous male but not female mice , 2020, JCI insight.

[46]  J. McMurray,et al.  Dapagliflozin in Patients with Chronic Kidney Disease. , 2020, The New England journal of medicine.

[47]  P. Sachdev,et al.  Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study , 2020, Diabetes Care.

[48]  P. Ponikowski,et al.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. , 2020, The New England journal of medicine.

[49]  R. Tian,et al.  Boosting NAD Level Suppresses Inflammatory Activation of PBMC in Heart Failure. , 2020, The Journal of clinical investigation.

[50]  E. Crimmins.  Social hallmarks of aging: Suggestions for geroscience research , 2020, Ageing Research Reviews.

[51]  M. Mattson,et al.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing , 2020, Nature Reviews Drug Discovery.

[52]  J. Kirkland,et al.  Senolytic drugs: from discovery to translation , 2020, Journal of internal medicine.

[53]  W. Tam,et al.  Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis , 2020 .

[54]  Michael E. Miller,et al.  Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells , 2020, Cell Reports.

[55]  S. Verma,et al.  Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors , 2020, JACC. Basic to translational science.

[56]  E. Ravussin,et al.  Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells , 2020, Cell.

[57]  P. Walter,et al.  The integrated stress response: From mechanism to disease , 2020, Science.

[58]  N. Barzilai,et al.  Benefits of Metformin in Attenuating the Hallmarks of Aging. , 2020, Cell metabolism.

[59]  P. Libby,et al.  Effects of Interleukin-1β Inhibition on Incident Anemia , 2020, Annals of Internal Medicine.

[60]  B. Liu,et al.  Role of Mitophagy in Cardiovascular Disease , 2020, Aging and disease.

[61]  C. Franceschi,et al.  One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project , 2020, GeroScience.

[62]  Kui Zhang,et al.  Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: results from meta-analysis. , 2020, Diabetes research and clinical practice.

[63]  A. Quyyumi,et al.  Circulating stem cells and cardiovascular outcomes: from basic science to the clinic. , 2019, European heart journal.

[64]  Toshiko Tanaka,et al.  Measuring biological aging in humans: A quest , 2019, Aging cell.

[65]  Andreas Keller,et al.  Undulating changes in human plasma proteome profiles across the lifespan , 2019, Nature Medicine.

[66]  Akshay S. Desai,et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.

[67]  W. Kraus,et al.  2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. , 2019, The lancet. Diabetes & endocrinology.

[68]  R. de Cabo,et al.  Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans. , 2019, Cell metabolism.

[69]  Shahrukh K Hashmi,et al.  Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease , 2019, EBioMedicine.

[70]  Adam L. Haber,et al.  Ketone Body Signaling Mediates Intestinal Stem Cell Homeostasis and Adaptation to Diet , 2019, Cell.

[71]  David M. Wilson,et al.  DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging. , 2019, American journal of human genetics.

[72]  W. E. Sanabria,et al.  Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial , 2019, The Lancet.

[73]  S. Mavrogeni,et al.  Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement , 2019, Heart Failure Reviews.

[74]  E. Heard,et al.  Advances in epigenetics link genetics to the environment and disease , 2019, Nature.

[75]  K. Lipska,et al.  Metformin in 2019. , 2019, JAMA.

[76]  C. Lang,et al.  A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial , 2019, European heart journal.

[77]  B. Zinman,et al.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. , 2019, The New England journal of medicine.

[78]  L. Ferrucci,et al.  A proteomic atlas of senescence-associated secretomes for aging biomarker development , 2019, bioRxiv.

[79]  H. Bøtker,et al.  Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients , 2019, Circulation.

[80]  P. Libby,et al.  Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure , 2019, Circulation.

[81]  B. Roberts,et al.  The Importance of Resistance Exercise Training to Combat Neuromuscular Aging. , 2019, Physiology.

[82]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[83]  Alex P. Reiner,et al.  DNA methylation GrimAge strongly predicts lifespan and healthspan , 2019, Aging.

[84]  S. Kritchevsky,et al.  Development of clinical trials to extend healthy lifespan , 2018, Cardiovascular endocrinology & metabolism.

[85]  D. DeMeo,et al.  DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure , 2018, Clinical Epigenetics.

[86]  N. Musi,et al.  Tau protein aggregation is associated with cellular senescence in the brain , 2018, Aging cell.

[87]  S. Austad,et al.  Aging as a Biological Target for Prevention and Therapy. , 2018, JAMA.

[88]  J. Qu,et al.  Epigenetic Modifications in Cardiovascular Aging and Diseases , 2018, Circulation research.

[89]  D. Sinclair,et al.  Sirtuins and NAD+ in the Development and Treatment of Metabolic and Cardiovascular Diseases , 2018, Circulation research.

[90]  L. Ferrucci,et al.  A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup , 2018, GeroScience.

[91]  D. Torella,et al.  Aged‐senescent cells contribute to impaired heart regeneration , 2018, bioRxiv.

[92]  T. Nawrot,et al.  Telomere Length as Cardiovascular Aging Biomarker: JACC Review Topic of the Week. , 2018, Journal of the American College of Cardiology.

[93]  L. Ferrucci,et al.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty , 2018, Nature Reviews Cardiology.

[94]  A. Terzic,et al.  The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential. , 2018, American journal of physiology. Renal physiology.

[95]  S. Bonassi,et al.  Frailty Syndrome and Genomic Instability in Older Adults: Suitability of the Cytome Micronucleus Assay As a Diagnostic Tool , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[96]  G. Tocci,et al.  EFFECT OF RESVERATROL ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED, CONTROLLED, CLINICAL TRIALS , 2018, Critical reviews in food science and nutrition.

[97]  M. Rich,et al.  Multimorbidity in Older Adults With Cardiovascular Disease. , 2018, Journal of the American College of Cardiology.

[98]  L. Fontana,et al.  Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[99]  J. Gil,et al.  Senescence and aging: Causes, consequences, and therapeutic avenues , 2018, The Journal of cell biology.

[100]  Jared M. Campbell,et al.  Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis , 2017, Ageing Research Reviews.

[101]  R. Holman,et al.  Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. , 2017, The lancet. Diabetes & endocrinology.

[102]  R. Collins,et al.  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial , 2017, The Lancet.

[103]  Saptarsi M. Haldar,et al.  Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice. , 2017, Cell metabolism.

[104]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[105]  E. Verdin,et al.  β-Hydroxybutyrate: A Signaling Metabolite. , 2017, Annual review of nutrition.

[106]  Christopher J. L. Murray,et al.  Inequalities in Life Expectancy Among US Counties, 1980 to 2014: Temporal Trends and Key Drivers , 2017, JAMA internal medicine.

[107]  J. Niebauer,et al.  Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. , 2017, American journal of physiology. Heart and circulatory physiology.

[108]  K. Mahaffey,et al.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes , 2017, The New England journal of medicine.

[109]  D. Promislow,et al.  A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs , 2017, GeroScience.

[110]  P. Robbins,et al.  New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463 , 2017, Aging.

[111]  D. Allison,et al.  Caloric restriction improves health and survival of rhesus monkeys , 2017, Nature Communications.

[112]  Matthew J. Crowley,et al.  Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease , 2017, Annals of Internal Medicine.

[113]  C. Conover,et al.  Senescent intimal foam cells are deleterious at all stages of atherosclerosis , 2016, Science.

[114]  Lawrence A Leiter,et al.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.

[115]  Shahrukh K Hashmi,et al.  Frameworks for Proof-of-Concept Clinical Trials of Interventions That Target Fundamental Aging Processes , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[116]  Shahrukh K Hashmi,et al.  Strategies and Challenges in Clinical Trials Targeting Human Aging , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[117]  Leslie A. Smith,et al.  Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice , 2016, Aging cell.

[118]  J. Zierath,et al.  Exercise Promotes Healthy Aging of Skeletal Muscle. , 2016, Cell metabolism.

[119]  John B Buse,et al.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. , 2016, The New England journal of medicine.

[120]  B. Kennedy,et al.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging. , 2016, Cell metabolism.

[121]  S. Hazen,et al.  Intestinal Microbiota‐Generated Metabolite Trimethylamine‐N‐Oxide and 5‐Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE‐Like Patient Cohort , 2016, Journal of the American Heart Association.

[122]  Dudley Lamming,et al.  Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer , 2016, Aging cell.

[123]  Cory B. Giles,et al.  Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors , 2016, Aging cell.

[124]  L. Sands,et al.  Effects of dietary protein intake on body composition changes after weight loss in older adults: a systematic review and meta-analysis. , 2016, Nutrition reviews.

[125]  R. Burgkart,et al.  Histone acetylation and methylation significantly change with severity of atherosclerosis in human carotid plaques. , 2016, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[126]  W. Kraus,et al.  Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial. , 2016, JAMA.

[127]  Claude Bouchard,et al.  Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits. , 2015, Cell metabolism.

[128]  N. LeBrasseur,et al.  The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs , 2015, Aging cell.

[129]  Michael E. Miller,et al.  Intentional Weight Loss and All-Cause Mortality: A Meta-Analysis of Randomized Clinical Trials , 2015, PloS one.

[130]  Jeffrey R Stout,et al.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) , 2014, Age and ageing.

[131]  L. Ford,et al.  Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders , 2014, Cancer Prevention Research.

[132]  Manuel Serrano,et al.  Cellular senescence: from physiology to pathology , 2014, Nature Reviews Molecular Cell Biology.

[133]  Daniel E Forman,et al.  Frailty assessment in the cardiovascular care of older adults. , 2014, Journal of the American College of Cardiology.

[134]  Z. D. Sharp,et al.  Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction , 2014, Aging cell.

[135]  A. Reiner,et al.  Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[136]  B. Ames,et al.  Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males , 2013, Aging cell.

[137]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[138]  D. Ingram,et al.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. , 2013, Cell metabolism.

[139]  L. Jasińska,et al.  Resveratrol in prostate diseases – a short review , 2013, Central European journal of urology.

[140]  M. Garcia-Conesa,et al.  Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective , 2013, Annals of the New York Academy of Sciences.

[141]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[142]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[143]  Albert Hofman,et al.  Nucleotide Excision DNA Repair Is Associated With Age-Related Vascular Dysfunction , 2012, Circulation.

[144]  E. Volpi,et al.  PAX7+ satellite cells in young and older adults following resistance exercise , 2012, Muscle & nerve.

[145]  E. Volpi,et al.  A moderate acute increase in physical activity enhances nutritive flow and the muscle protein anabolic response to mixed nutrient intake in older adults. , 2012, The American journal of clinical nutrition.

[146]  E. Sahin,et al.  Telomeres and Mitochondria in the Aging Heart , 2012, Circulation research.

[147]  P. Rabinovitch,et al.  Mitochondria and cardiovascular aging. , 2012, Circulation research.

[148]  A. Salminen,et al.  AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network , 2012, Ageing Research Reviews.

[149]  Pankaj Kapahi,et al.  Cellular senescence: a link between cancer and age-related degenerative disease? , 2011, Seminars in cancer biology.

[150]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[151]  Harlan M Krumholz,et al.  Cardiac care for older adults. Time for a new paradigm. , 2011, Journal of the American College of Cardiology.

[152]  L. Ferrucci,et al.  Body Fat Distribution and Inflammation Among Obese Older Adults With and Without Metabolic Syndrome , 2010, Obesity.

[153]  S. Blair,et al.  Mortality trends in the general population: the importance of cardiorespiratory fitness , 2010, Journal of psychopharmacology.

[154]  M. Turunen,et al.  Epigenetics and atherosclerosis. , 2009, Biochimica et biophysica acta.

[155]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[156]  Stuart M Phillips.  Physiologic and molecular bases of muscle hypertrophy and atrophy: impact of resistance exercise on human skeletal muscle (protein and exercise dose effects). , 2009, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[157]  T. Gill,et al.  A standard procedure for creating a frailty index , 2008, BMC geriatrics.

[158]  S. Fujita,et al.  Aerobic Exercise Overcomes the Age-Related Insulin Resistance of Muscle Protein Metabolism by Improving Endothelial Function and Akt/Mammalian Target of Rapamycin Signaling , 2007, Diabetes.

[159]  I. Komuro,et al.  Vascular Cell Senescence: Contribution to Atherosclerosis , 2007, Circulation research.

[160]  I. V. Van Gelder,et al.  Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation , 2006, Circulation research.

[161]  Matt Kaeberlein,et al.  Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients , 2005, Science.

[162]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[163]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[164]  P. Rabinovitch,et al.  Modulating mTOR in aging and health. , 2015, Interdisciplinary topics in gerontology.